Search results for " Color"
showing 10 items of 770 documents
Real-Time Monocular Segmentation and Pose Tracking of Multiple Objects
2016
We present a real-time system capable of segmenting multiple 3D objects and tracking their pose using a single RGB camera, based on prior shape knowledge. The proposed method uses twist-coordinates for pose parametrization and a pixel-wise second-order optimization approach which lead to major improvements in terms of tracking robustness, especially in cases of fast motion and scale changes, compared to previous region-based approaches. Our implementation runs at about 50–100 Hz on a commodity laptop when tracking a single object without relying on GPGPU computations. We compare our method to the current state of the art in various experiments involving challenging motion sequences and diff…
A Red Eye Colour Mutation in Culex pipiens after X-irradiation
1963
FOUR 1–2-day-old males of Culex pipiens were irradiated with a dose of 4,000 r. The mutant ‘red eye’ (r) was isolated from F3 cultures of two of the irradiated males (♂ II and ♂ IV). From male II, there were three red-eyed females which arose out of a single F2 brother–sister mating; from male IV, 80 red-eyed females and one red-eyed male from 14 F2 brother–sister matings. According to the experimental procedure, this means that at least one sperm from male II and at least fourteen sperms from male IV carried the mutation r. Thus, the same mutation was recovered in parallel from two irradiated males. The clustered appearance of the mutation in male IV was presumably caused by the occurrence…
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta…
2019
Background: Tissue evaluation for RAS (KRAS or NRAS) gene status in metastatic colorectal cancer (mCRC) patients represent the standard of care to establish the optimal therapeutic strategy. Unfortunately, tissue biopsy is hampered by several critical limitations due to its invasiveness, difficulty to access to disease site, patient’s compliance and, more recently, neoplastic tissue spatial and temporal heterogeneity. Methods: The authors performed a systematic literature review to identify available trials with paired matched tissue and ctDNA RAS gene status evaluation. The authors searched EMBASE, MEDLINE, Cochrane, www.ClinicalTrials.gov , and abstracts from international meetings. In to…
Measurement of the mass of the W boson using direct reconstruction at √s = 183 GeV
1999
From data corresponding to an integrated luminosity of 53.5 pb(-1) taken during the 183 GeV run in 1997, DELPHI has measured the W mass from direct reconstruction of WW --> lq (q) over bar and WW --> q (q) over bar q (q) over bar events. Combining these channels, a value of m(w) = 80.238 +/- 0.154(stat) +/- 0.035(syst) +/- 0.035(fsi) +/- 0.021 (LEP) GeV/c(2) is obtained, where fsi denotes final state interaction. Combined with the W mass obtained by DELPHI from the WW production cross-section and with the direct measurement at 172 GeV this leads to a measured value of m(w) = 80.270 +/- 0.137(stat) +/- 0.031(syst) +/- 0.030(fsi) +/- 0.021(LEP)GeV/c(2), in good agreement with the Standard Mod…
A Method for Measurements of the Total 2H(γ,π−)PP Cross Sections at Threshold
1979
In recent years measurements of the total cross section for the reactions 2H(γ,π+ nn) and 2H(γ,π0)2H close to the production threshold were performed1. For the 2H(γ,π−)pp reaction data of similar good quality doesn’t exist. In this paper a method is prescribed and the feasibility for the reaction 2H(γ,π−)pp is demonstrated. Figure 1 shows the principle: The photon beam hits a liquid or high pressured gas target of 2H. π− are created on the deuteron and stopped in the same target cell. The major part of the tt are captured π− are captured by deuterons via the reaction 2H(π−,n)n. The energy is shared equally by the two neutrons (En= 68.2 MeV). One of these monochromatic neutrons is detected b…
A novel approach to measure the cross section of the 18O(p, α)15N resonant reaction in the 0-200 keV energy range
2009
The 18O(p, ?)15N reaction is of primary importance to pin down the uncertainties, due to nuclear physics input, affecting present-day models of asymptotic giant branch stars. Its reaction rate can modify both fluorine nucleosynthesis inside such stars and oxygen and nitrogen isotopic ratios, which allow one to constrain the proposed astrophysical scenarios. Thus, an indirect measurement of the low-energy region of the 18O(p, ?)15N reaction has been performed to access, for the first time, the range of relevance for astrophysical application. In particular, a full, high-accuracy spectroscopic study of the 20 and 90 keV resonances has been performed and the strengths deduced to evaluate the r…
Influence of solar and sensor angles on chlorophyll estimation for geostationary ocean color imager
2012
The impact of the solar and sensor angles on band-ratio chlorophyll concentration (Chl) estimation in Case 1 waters (open ocean) is analyzed in this work. The error range of Chl estimation due to angular variation is evaluated. The radiative transfer code Hydrolight is used for remote sensing reflectance simulation for 20 spectral bands. OC4v4 algorithm is used for Chl estimation. The results indicate that the error range of Chl estimation is between -41.91% and +46.15% when Chl range is from 0.0425 mg/m 3 to 10.6685 mg/m 3 and the solar and sensor zenith angles vary between 0 and 80°. This study provides a reference to determine the effective observation area of a future multispectral or h…
TRIPLET SCHEDULE OF WEEKLY 5-FLUOROURACIL AND ALTERNATING IRINOTECAN OR OXALIPLATIN IN ADVANCED COLORECTAL CANCER: A DOSE-FINDING AND PHASE II STUDY.
2010
A weekly administration of alternating irinotecan or oxaliplatin associated to 5-Fluorouracil in advanced colorectal cancer was planned in order to evaluate a new schedule maintaining dose intensities of each drug as in double combinations and tolerability of the triplet association. The following weekly schedule was administered: irinotecan, days 1 and 15; oxaliplatin, days 8 and 22; 5-fluorouracil (5-FU) over 12-h (from 10:00 p.m. to 10:00 a.m.) timed flat infusion, days 1-2, 8-9, 15-16 and 22-23, every 4 weeks. Dose- finding and phase II study were planned. Thirteen patients were enrolled in the dose-finding study and 23 in the phase II study. The recommended doses of our study are: irin…
Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of…
2005
Abstract Background A biweekly regimen of irinotecan 200 mg/m2 on day 1 and levo-leucovorin (LV) 250 mg/m2 plus 5-fluorouracil (5-FU) 850 mg/m2 via intravenous bolus on day 2 was assessed in 2 consecutive randomized trials in metastatic colorectal cancer (CRC). Patients and Methods Individual data of 254 patients were merged, and baseline features potentially affecting overall response rate (ORR), progression-free survival (PFS),overall survival (OS), and occurrence of severe toxicity were analyzed by univariate and multivariate analyses. Results In the pooled series, ORR was 33% (95% confidence interval [CI], 27%-39%). Liver-only disease (47% vs. 25%; P = 0.0012) and absence of previous we…
“Bevacizumab (Bev), irinotecan (IRI), folinic acid (FA), and 5-fluorouracil (FU) every 2 weeks (BIFF regimen) as first-line treatment for metastatic …
2009
e15067 Background: The IRIFAFU regimen produced in MCRC pts a consistent activity (RR, 33% [95% CI, 27–39%], PFS, 7.4 [95% CI, 6.5–8.3] mo.) in 2 consecutive randomized SICOG trials . Bev was proven to significantly improve the efficacy of IFL regimen. Here we report the safety and activity results of the BIFF regimen as first-line treatment of MCRC. Patients: From Feb 2007 to Jul 2008, 95 pts with MCRC were treated: so far, 85 pts were evaluated for safety: M/F were 47/38, median age (range) was 64 (35–78) yrs. Fifty-six pts had a colon, and 29 pts a rectal carcinoma. ECOG PS was 0 (63 pts, 74%), or 1 (22 pts, 26%). Thirty-four (40%) pts had 1 site, 33 (39%) 2 sites, and 18 (21%) pts ≥3 s…